Common use of Assay Development Clause in Contracts

Assay Development. (a) The Screening Committee will allocate responsibilities between the parties for specific assay development tasks. In general, Neurocrine will develop the appropriate biochemical and/or cellular reagents for the assay and provide necessary quantities to Caliper for LabChip Assay development and screening. Initially, Caliper will direct work to adapt the assay into the LabChip format. Over time, the parties expect that Neurocrine will assume an increasing role in LabChip Assay development. The parties will arrange for Neurocrine scientists to train in LabChip Assay development at Caliper and/or for certain LabChip Assay development tools to be provided to Neurocrine. The Screening Committee will determine, or establish criteria for others to determine, when a LabChip Assay is ready for screening on Caliper's high throughput system. (b) Caliper and Neurocrine shall each use commercially reasonable efforts to collaboratively develop LabChip Assays for the Targets selected by the Screening Committee. The parties intend to [ * ]. Therefore, the parties have [ * ]. The parties may mutually agree to pursue such research for certain Targets, but Caliper shall not be required under this Agreement to [ * ].